Telo Genomics Corp. (TELO) Reports Preliminary TELO—MRD Data vs clonoSEQ and EuroFlow
Telo Genomics reported preliminary research where blood-based TELO enumeration detected circulating plasma cells in all evaluable clonoSEQ-positive cases and in clonoSEQ-negative or non-evaluable samples; prior EuroFlow data showed 92.9% TELO vs 54.8% EuroFlow detection in a small matched cohort.Ma…